GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Trading 12-11 14:51:19 EST

48.65

+0.24

+0.50%

High48.95	Low48.45	Vol2.34M
Open48.47	D1 Closing48.41	Amplitude1.03%
Mkt Cap99.19B	Tradable Cap94.72B	Total Shares2.04B
T/O113.79M	T/O Rate0.12%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":48.6542,"timestamp":1765482668912,"preClose":48.41,"halted":0,"volume":2335148,"delay":0,"floatShares":1946891708,"shares":2038624800,"eps":3.572046,"marketStatus":"Trading","change":0.2442,"latestTime":"12-11 14:51:19 EST","open":48.47,"high":48.95,"low":48.45,"amount":113792794.175416,"amplitude":0.010328,"askPrice":48.66,"askSize":608,"bidPrice":48.65,"bidSize":326,"shortable":3,"etf":0,"ttmEps":3.572046,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":48.41,"dividendRate":0.035169,"preHourTrading":{"tag":"盘前","latestPrice":48.5,"preClose":48.41,"latestTime":"09:29 EST","volume":221014,"amount":10701403.94905,"timestamp":1765463392090},"postHourTrading":{"tag":"盘后","latestPrice":48.41,"preClose":48.41,"latestTime":"19:56 EST","volume":18076,"amount":875077.59,"timestamp":1765414613656},"volumeRatio":0.840177,"impliedVol":0.262,"impliedVolPercentile":0.26},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"2590545632","title":"RPT-UPDATE 2-US FDA expands use of GSK's Blujepa as treatment for gonorrhea","url":"https://stock-news.laohu8.com/highlight/detail?id=2590545632","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590545632?lang=en_us&edition=fundamental","pubTime":"2025-12-12 02:45","pubTimestamp":1765478701,"startTime":"0","endTime":"0","summary":"RPT-UPDATE 2-US FDA expands use of GSK's Blujepa as treatment for gonorrheaRepeats story to remove hyperlink in paragraph 8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL4N3XH1DB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0575583348.USD","SG9999001176.SGD","LU1400636491.USD","SG9999011175.SGD","IE00BQJZX424.USD","IE00BLSP4452.SGD","LU1098665638.USD","LU1400636574.HKD","LU1400636657.SGD","LU0161305163.EUR","LU1487256676.USD","LU1228905037.USD","LU0058720904.USD","LU0456855351.SGD","BK4007","LU0170899867.USD","IE00B19Z3581.USD","LU0109981661.USD","LU0545562505.USD","LU1046248800.SGD","LU0203347892.USD","BK4588","IE00B3T34201.USD","SG9999001176.USD","SG9999002224.SGD","LU0868494617.USD","BK4550","BK4581","LU0306807586.USD","SGXZ57979304.SGD","IE0002270589.USD","LU0321505439.SGD","BK4568","IE00BBT3K403.USD","LU1481600234.SGD","LU1894683348.USD","LU1066053197.SGD","BK4599","SG9999002232.USD","IE00BLSP4239.USD","LU1057294990.SGD","BK4585","LU1228905540.USD","SG9999013999.USD","LU0234572021.USD","IE0034235071.USD","LU1670756490.USD","LU0971552830.HKD","LU1064927863.SGD","SG9999003800.SGD","LU0985481810.HKD","LU1645745479.HKD","BK4533","LU1302929846.USD","LU1894683264.USD","LU0225771236.USD","LU0122379950.USD","BK5011","IE00BWDBJ516.SGD","GSK","BK4592","LU0321505868.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4534","LU1023059063.AUD","LU0225284248.USD","LU0289739699.SGD","LU0211331839.USD","LU0306806265.USD","LU1309081286.SGD","LU1883839398.USD","LU1035777561.USD","LU1481599808.USD","LU0203345920.USD","LU0971552673.USD","LU1015430645.USD","IE000M9KFDE8.USD","LU1202635105.USD"],"gpt_icon":0},{"id":"2590763300","title":"GSK Says Risvutatug Rezetecan Gets FDA Orphan Drug Designation For Small-Cell Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2590763300","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590763300?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:19","pubTimestamp":1765358375,"startTime":"0","endTime":"0","summary":"GSK  said Wednesday that risvutatug rezetecan has received the orphan drug designation from the US Food and Drug Administration to treat small-cell lung cancer.The status was granted based on preliminary data demonstrating \"durable responses\" in patients with extensive-stage cancer in a phase I clinical trial, the company said.Risvutatug rezetecan has now received five regulatory designations, according to GSK.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","BK4007","GSK.UK","BK4532","GSK","BK4585","BK4588"],"gpt_icon":0},{"id":"2590307701","title":"GSK Forms Collaboration With Oxford BioTherapeutics to Discover Antibody-Based Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2590307701","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590307701?lang=en_us&edition=fundamental","pubTime":"2025-12-10 16:58","pubTimestamp":1765357086,"startTime":"0","endTime":"0","summary":"GSK  has formed a strategic collaboration with Oxford BioTherapeutics to discover antibody-based cancer treatments, the UK-based oncology company said Wednesday.The multi-year collaboration leverages GSK's drug development capabilities and Oxford's OGAP-Verify discovery platform to identify potential candidates, which will be validated through joint research, Oxford said.The deal entitles Oxford to receive an undisclosed upfront payment, potential milestone payments and sales royalties.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861217088.USD","LU0106831901.USD","LU1668664300.SGD","LU1861220207.SGD","LU1791807156.HKD","BK4532","BK4585","DFS","GSK","LU1829250122.USD","BK4588","OXM","LU2360107671.USD","BK4166","BK4007","GSK.UK","BK4202"],"gpt_icon":0},{"id":"2590323958","title":"GSK Slips Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2590323958","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590323958?lang=en_us&edition=fundamental","pubTime":"2025-12-10 01:05","pubTimestamp":1765299900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares dropped 2.06% to GBP17.83 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index  falling 0.03% to 9,642.01.GSK PLC closed 3.80% below its 52-week high of GBP18.54, which the company achieved on December 4th.Trading volume totaled 4.8 million, compared to the 50-day average of 9.4 million.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2590315296","title":"Is GSK’s Exit and IDE034’s FDA Green Light Reframing the Investment Case For IDEAYA Biosciences (IDYA)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590315296","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590315296?lang=en_us&edition=fundamental","pubTime":"2025-12-09 11:15","pubTimestamp":1765250157,"startTime":"0","endTime":"0","summary":"In early December 2025, GSK notified IDEAYA Biosciences that it will terminate their 2020 collaboration, returning the Werner Helicase (IDE275) and Pol Theta (IDE705) programs, while IDEAYA also secured FDA clearance to begin a Phase 1 trial of its bispecific B7H3/PTK7 ADC IDE034 for multiple solid tumors in 2026.\nThis combination of a major partnership unwind and the advancement of a potentially first-in-class oncology asset highlights IDEAYA’s increasing control over its pipeline and its...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/is-gsks-exit-and-ide034s-fda-green-light-reframing-the-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/is-gsks-exit-and-ide034s-fda-green-light-reframing-the-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4139","BK4532","GSK.UK","LU1829250122.USD","GSK","BK4585","BK4588","IDYA"],"gpt_icon":0},{"id":"2589814159","title":"Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns","url":"https://stock-news.laohu8.com/highlight/detail?id=2589814159","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589814159?lang=en_us&edition=fundamental","pubTime":"2025-12-06 02:30","pubTimestamp":1764959447,"startTime":"0","endTime":"0","summary":"Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newbornsBy Mrinalika Roy and Michael Erman","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL1N3XB0QF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0070302665.USD","LU0109981661.USD","LU0985481810.HKD","LU1989772923.USD","LU0225771236.USD","LU2023250504.SGD","LU0321505868.SGD","BK4007","LU2461242641.AUD","MRK","LU1037948541.HKD","IE00BWDBJ516.SGD","LU1069347547.HKD","LU0965508806.USD","LU1400636491.USD","GSK","LU0861579265.USD","LU0211331839.USD","LU2468319806.SGD","SG9999001440.SGD","LU1066051811.HKD","BK4516","LU0161305163.EUR","SG9999002224.SGD","LU2112291526.USD","LU1066051225.USD","LU0320765489.SGD","LU1202635105.USD","BK4534","IE0034235071.USD","LU0321505439.SGD","LU0265550359.USD","LU1481599808.USD","LU2106854487.HKD","LU1934455277.USD","LU0965509283.SGD","LU0098860793.USD","LU0234572021.USD","LU1061106388.HKD","LU1093756168.USD","LU1571399168.USD","IE00BLSP4452.SGD","LU2361044865.SGD","LU1116320737.USD","SG9999015358.SGD","LU1098665638.USD","LU0106261372.USD","SG9999013999.USD","IE00BJT1NW94.SGD","LU0203347892.USD","LU1481600234.SGD","LU1934455194.USD","IE00B3T34201.USD","LU1035777561.USD","LU2361044949.HKD","LU1989772840.SGD","LU1302929846.USD","BK4550","IE00BQJZX424.USD","LU0545562505.USD","SG9999015341.SGD","LU1934455863.HKD","LU1023059063.AUD","LU1162221912.USD","LU1035773651.USD","LU0306807586.USD","LU1699723380.USD","IE00B4R5TH58.HKD","LU1046248800.SGD","IE00BLSP4239.USD","LU0266013472.USD","IE000M9KFDE8.USD","LU1015430645.USD","LU0006306889.USD","LU1989771016.USD","IE00B1BXHZ80.USD","LU1917777945.USD","LU1941712348.USD","LU0122379950.USD","SG9999014575.USD","LU2324357040.USD","LU1093756325.SGD","LU1941712264.USD","LU1291159041.SGD","BK4585","LU1974910355.USD","BK5011","SG9999002232.USD","LU1228905540.USD","LU1430594728.SGD","LU0965509010.AUD","IE00BSNM7G36.USD","LU2023250843.SGD","LU0238689110.USD","LU0320765646.SGD","LU1929549753.HKD","LU2361045086.USD","SNY","LU1400636574.HKD","LU0203345920.USD","BK4559","SG9999014559.SGD","SGXZ57979304.SGD","LU0575583348.USD","LU0208291251.USD","SG9999014542.SGD","SG9999001176.USD","SG9999014567.USD","LU2089984988.USD","IE00BN8TJ469.HKD","LU1057294990.SGD","LU0971552830.HKD","LU0225284248.USD","LU0965509101.SGD","LU0306806265.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0985320562.USD","LU1228905037.USD","BK4588","LU1585245621.USD","LU1064927863.SGD","IE00B2B36J28.USD","LU1400636657.SGD","LU1066051498.USD","LU1983299246.USD","IE00BBT3K403.USD","LU1645745479.HKD","LU1487256676.USD","IE00BJJMRZ35.SGD","LU1037948897.HKD","LU0058720904.USD","LU1309081286.SGD","LU1670756490.USD","IE0002141913.USD","BK4533","SG9999001176.SGD","LU0971552673.USD","LU1116320901.HKD","LU1066053197.SGD","LU0265550946.USD"],"gpt_icon":0},{"id":"2589811860","title":"GSK Slides Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2589811860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589811860?lang=en_us&edition=fundamental","pubTime":"2025-12-06 01:07","pubTimestamp":1764954420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  slipped 1.15% to GBP18.05 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.45% to 9,667.01.GSK PLC closed 2.62% short of its 52-week high of GBP18.54, which the company achieved on December 4th.Trading volume totaled 3.5 million, compared to the 50-day average of 9.6 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2588025837","title":"AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2588025837","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588025837?lang=en_us&edition=fundamental","pubTime":"2025-12-04 01:24","pubTimestamp":1764782640,"startTime":"0","endTime":"0","summary":"UK invites pharma executives to help design a new drug-pricing system following a fresh US–UK agreement that raises NHS costs but protects medicine exports.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/03/Konskie--Poland---January-03--2024-Astra.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/03/Konskie--Poland---January-03--2024-Astra.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49190399/astrazeneca-gsk-among-executives-asked-to-help-redesign-uk-pricing-rules-report","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49190399/astrazeneca-gsk-among-executives-asked-to-help-redesign-uk-pricing-rules-report","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0289739699.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1989772923.USD","LU1093756325.SGD","LU2023250504.SGD","LU0985320562.USD","LU1291159041.SGD","LU2461242641.AUD","MRK","IE00BJT1NW94.SGD","LU1037948541.HKD","SG9999015358.SGD","LU1934455194.USD","IE00BSNM7G36.USD","GSK","LU0861579265.USD","LU2361044949.HKD","LU0211331839.USD","BK4532","IE00B2B36J28.USD","LU1989772840.SGD","LU2468319806.SGD","SG9999001440.SGD","LU1934455863.HKD","BK4516","LU0320765489.SGD","LU0265550359.USD","AZN","LU0208291251.USD","LU1699723380.USD","LU2089984988.USD","IE00BN8TJ469.HKD","IE0002141913.USD","LU2462157665.USD","SG9999001176.SGD","LU2456880835.USD","IE00BLSP4239.USD","LU0234572021.USD","LU0266013472.USD","LU1989771016.USD","GSK.UK","IE00B1BXHZ80.USD","LU1066053197.SGD","LU0965509101.SGD","LU2361044865.SGD","LU0265550946.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2588057618","title":"Market Chatter: AstraZeneca, GSK to Join UK Working Group on New Drug-Pricing Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=2588057618","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588057618?lang=en_us&edition=fundamental","pubTime":"2025-12-03 00:32","pubTimestamp":1764693131,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) and GSK (GSK) will be invited to join a UK government panel tasked with shaping a new drug-pricing framework to replace the Voluntary Scheme for Branded Medicines Pricing and Access,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","LU1829250122.USD","LU2236285917.USD","BK4585","LU0109394709.USD","LU2456880835.USD","LU0889565916.HKD","LU2462157665.USD","LU0320765992.SGD","AZN","BK4007","BK4532","BK4568","GSK","BK4588","LU2417539215.USD"],"gpt_icon":0},{"id":"2588052084","title":"European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2588052084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588052084?lang=en_us&edition=fundamental","pubTime":"2025-12-03 00:11","pubTimestamp":1764691909,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.58% to 1,633.19 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and 3D printer firm Materialise , which climbed 7.4% and 2.4% respectively. They were followed by lender ING Group  and biopharmaceutical company argenx , which advanced 2.1% and 1.5% respectively.The decliners from continental Europe were led by consumer goods company Unilever  and pharmaceutical company Novo Nordisk , which fell 1.5% and 1.3% respectively. They were followed by accommodations booking company trivago  and internet advertising firm Criteo , which were off 1% and 0.9% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company GSK  and telecommunications operator Vodafone Group , which rose 2.1% and 2.0% respectively. They were followed by lender Lloyds Banking Group , which was up 1.9%.The dec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4183","BK4077","BK4599","BK4132","BK4139","LU0889565916.HKD","ARGX","IE00B2B36J28.USD","LU0320765992.SGD","BK7141","ULVR.UK","MTLS","LU2324357040.USD","SQNS","BK4141","GSK","BK4532","BK4592","UL","ING","CRTO","IE00BKVL7J92.USD","IE00BFTCPJ56.SGD","VOD","BK4117","IE00BZ1G4Q59.USD","DAVA","GSK.UK","BK4134","WPP.AU","IE00BJJMRZ35.SGD","IE00BFMHRM44.USD","LU1093756325.SGD","ING.AU","IE00BJT1NW94.SGD","AFG","DAVA.AU","TRVG","LU0689626769.HKD","NVO.AU","WPP","BK4546","BK7104","UN","LU0084288595.USD","BK4521","SLN","MREO","LYG"],"gpt_icon":1},{"id":"2586200786","title":"A Look at AnaptysBio's Valuation as Litigation With GSK Over Jemperli Royalties Draws Investor Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2586200786","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586200786?lang=en_us&edition=fundamental","pubTime":"2025-11-28 15:20","pubTimestamp":1764314446,"startTime":"0","endTime":"0","summary":"AnaptysBio, Inc. finds itself in the spotlight after launching a legal action against GSK’s subsidiary Tesaro regarding the collaboration agreement for Jemperli, their oncology drug. The ongoing dispute raises questions about future royalty streams and the company’s strategic direction.\nSee our latest analysis for AnaptysBio.\nAnaptysBio’s share price has surged 215.6% year-to-date, with recent legal sparring over Jemperli bringing extra scrutiny and a sense of renewed momentum. After trading...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/a-look-at-anaptysbios-valuation-as-litigation-with-gsk-over","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/a-look-at-anaptysbios-valuation-as-litigation-with-gsk-over","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ANAB","BK4588","LU1829250122.USD","BK4532","GSK","GSK.UK","BK4139","BK4585","BK4007"],"gpt_icon":0},{"id":"2586742264","title":"GSK price target raised to 1,660 GBp from 1,600 GBp at Berenberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2586742264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586742264?lang=en_us&edition=fundamental","pubTime":"2025-11-27 02:20","pubTimestamp":1764181217,"startTime":"0","endTime":"0","summary":"Berenberg analyst Kerry Holford raised the firm’s price target on GSK (GSK) to 1,660 GBp from 1,600 GBp and keeps a Hold rating on the shares. Publ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1660-gbp-from-1600-gbp-at-berenberg-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1660-gbp-from-1600-gbp-at-berenberg-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"gpt_icon":0},{"id":"2586235537","title":"GlaxoSmithKline (GSK) Receives a Hold from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2586235537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586235537?lang=en_us&edition=fundamental","pubTime":"2025-11-26 14:36","pubTimestamp":1764138965,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Hold rating on GlaxoSmithKline, with a price target of $43.00. Holfo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-berenberg-bank-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-berenberg-bank-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","BK4588","GSK","BK4532","LU1829250122.USD","BK4585"],"gpt_icon":0},{"id":"2586138288","title":"U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2586138288","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586138288?lang=en_us&edition=fundamental","pubTime":"2025-11-26 08:22","pubTimestamp":1764116520,"startTime":"0","endTime":"0","summary":"The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening an effort to rein in drug costs.The new prices, which will take effect in 2027, shave 38% to 85% off the list prices for drugs for diseases including asthma, cancer and diabetes. The reductions are estimated to save Medicare, the health-insurance program for the elderly, $12 billion.For some patients, the lower prices could reduce spending on copays or other out-of-pocket charges imposed by their particular plan. Other patients taking the drugs might not see a direct savings, however, because they have fixed monthly copays.Also, Medicare members now have a $2,000 annual cap on out-of-pocket drug costs. Yet the savings could help curb growth in plan premiums.In addition to Ozempic, other drugs that will cost Medicare less thanks to the negotiations include GSK's Trelegy asthma treatment, Pfizer's breast-cancer therapy Ibrance and Merck diabetes pill Janum","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU2461242641.AUD","IE00BN8TJ469.HKD","LU1162221912.USD","LU1917777945.USD","LU0211331839.USD","LU2361044865.SGD","IE00BLSP4452.SGD","LU0266013472.USD","LU0965509101.SGD","IE0002141913.USD","LU2361044949.HKD","IE00BLSP4239.USD","LU1093756168.USD","LU2361045086.USD","LU1023059063.AUD","LU0289739699.SGD","LU0070302665.USD","SG9999002232.USD","GSK","GSK.UK","LU0006306889.USD","LU0208291251.USD","LU0965508806.USD","LU0265550359.USD","LU2023250843.SGD","LU1983299246.USD","LU2106854487.HKD","IE00BSNM7G36.USD","LU1934455277.USD","IE0009355771.USD","LU1035773651.USD","SG9999015341.SGD","BK4550","LU0203345920.USD","LU2324357040.USD","LU1037948897.HKD","SG9999001176.SGD","MRK","SG9999014559.SGD","BK4532","LU0320765489.SGD","LU1941712348.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4585","LU0122379950.USD","LU0058720904.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2586420351","title":"Berenberg Raises Price Target on GSK to $43 From $41, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2586420351","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586420351?lang=en_us&edition=fundamental","pubTime":"2025-11-25 20:04","pubTimestamp":1764072249,"startTime":"0","endTime":"0","summary":"GSK's (GSK) US stock has an average rating of overweight and mean price target of $47.53, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK"],"gpt_icon":0},{"id":"2586342901","title":"Deutsche Bank  Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586342901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586342901?lang=en_us&edition=fundamental","pubTime":"2025-11-25 18:15","pubTimestamp":1764065732,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline, with a price target of £16.00. Papad...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-remains-a-hold-on-glaxosmithkline-gsk-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-remains-a-hold-on-glaxosmithkline-gsk-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4118","BK4585","LU1829250122.USD","BK4007","GSK","GSK.UK","BK4566","DB","BK4532","BK4588","BK4552"],"gpt_icon":0},{"id":"2585464399","title":"AnaptysBio Presents Opportunity Despite 'Near-Term Turbulence' Amid Legal Dispute with GSK, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2585464399","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585464399?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:32","pubTimestamp":1763987568,"startTime":"0","endTime":"0","summary":"AnaptysBio  presents an opportunity despite \"near-term turbulence,\" with downside limited by the $100 million stock buyback and potential upside from settlement terms or new rheumatoid arthritis development plans in the first half of 2026, Wedbush Securities said in a note Monday.Wedbush said it remains \"mindful\" of the possibility of a settlement in the ongoing legal dispute between AnaptysBio and GSK  before the scheduled trial date in July 2026.However, Wedbush analysts said they are not modeling any potential settlement due to lack of detail, in order to remain conservative. Wedbush, however, speculated that a possible outcome could involve GSK continuing development of antibody-drug conjugates with Keytruda in exchange for financial concessions to AnaptysBio.In relation to the $100 million share repurchase, Wedbush believes it \"provides downside protection should volatility drive shares lower in the meantime, and we see the expiration period of March 2026 as suggestive a settlemen","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK","LU1829250122.USD","BK4532","ANAB","BK4007","BK4585","GSK.UK","BK4588","BK4139"],"gpt_icon":0},{"id":"2585146449","title":"Sector Update: Health Care Stocks Rise Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2585146449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585146449?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:14","pubTimestamp":1763734474,"startTime":"0","endTime":"0","summary":"Health care stocks were rising pre-bell Friday, with the Health Care Select Sector SPDR Fund  up 0.4% and the iShares Biotechnology ETF  0.1% higher.Azenta  shares were up more than 23% after the company posted higher fiscal Q4 non-GAAP earnings and revenue.AnaptysBio  stock was down more than 13% after the company said it filed a complaint in Delaware Chancery Court seeking a declaration that GSK  unit Tesaro has \"materially breached\" the companies' collaboration deal covering cancer drug Jemperli. Tesaro also filed a lawsuit accusing AnaptysBio of breaching their license agreement.Veeva Systems  shares were down nearly 8% even after the company reported higher fiscal Q3 non-GAAP earnings and revenue, and raised its fiscal 2026 guidance.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","LU0266013472.USD","ANAB","AZTA","LU1989764748.USD","IE0031619046.USD","LU0012050646.USD","LU1169590202.USD","IE00B7SZL793.SGD","VEEV","BK4504","LU2065732104.USD","IBB","BK4585","BK4581","LU0289739699.SGD","GSK","BK4167","LU0058720904.USD","BK4528","GSK.UK","LABU","LU0106261612.USD","LU0170899867.USD","LU1169589451.USD","BK4532","XBI","BK4139","XLV","IE00B19Z4B17.USD","IE00B66KJ199.SGD","LU1829250122.USD","BK4613","BK4534","BK4007","BK4147","BK4588","LU1989764664.SGD"],"gpt_icon":1},{"id":"2585146890","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday on Reignited Rate Cut Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2585146890","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585146890?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:57","pubTimestamp":1763733425,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5% and the actively traded Invesco QQQ Trust (QQQ) was 0.5% higher in Friday's premarket activity as a Federal Reserve offic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLK","VIS","FAS","SLV","SOXX","IYW","UNG","XLI","XLP","XSD","INTU","XLY","IVV","XRT","EEM","IGM","TM","EETH","XLE","FRO","IBB","IYJ","BITO","SPY.AU","FAZ","ANAB","SPY","XLF","IYE","VHT","XLV","WTM","IYH","NVRI","USO","RTH.AU","RTH","VDC",".DJI","IPK",".IXIC","GSK","WTM.AU","EQR","VHT.AU","IYK","BETH"],"gpt_icon":1},{"id":"2585314822","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2585314822","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585314822?lang=en_us&edition=fundamental","pubTime":"2025-11-21 20:47","pubTimestamp":1763729230,"startTime":"0","endTime":"0","summary":"Q/C Technologies  shares were 15% lower pre-bell Friday following a 1.2% gain in the previous session.AnaptysBio  stock was down 14% after the company said it is suing GSK's  Tesaro unit over an alleged breached of their collaboration agreement covering cancer drug Jemperli.Albemarle  shares were 5% lower, adding to losses from the previous session.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2106854487.HKD","LU0823414551.USD","BK4545","LU1829250122.USD","LU2357125470.USD","LU1548497426.USD","LU2357305700.SGD","BK4532","LU1878469433.USD","LU2506951792.HKD","BK4585","LU1720051108.HKD","GSK","LU1861214812.USD","QCLS","LU1803068623.USD","LU1244550494.USD","LU1244550577.SGD","LU1720051017.SGD","BK4109","BK4588","LU0823414478.USD","ANAB","LU1861219969.SGD","LU2023250504.SGD","GSK.UK","LU1974910355.USD","BK4548","LU2249611893.SGD","ALB.AU","LU2294711713.HKD","ALB","LU1917777945.USD","LU1244550221.USD","BK7095","BK4007","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0114},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.1671},{"period":"6month","weight":0.1848},{"period":"1year","weight":0.3749},{"period":"ytd","weight":0.4314}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.577778,"avgChangeRate":0.012956},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.001972},{"month":3,"riseRate":0.622222,"avgChangeRate":0.021018},{"month":4,"riseRate":0.673913,"avgChangeRate":0.032633},{"month":5,"riseRate":0.413043,"avgChangeRate":-0.008096},{"month":6,"riseRate":0.586957,"avgChangeRate":0.009648},{"month":7,"riseRate":0.543478,"avgChangeRate":0.003945},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.013901}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}